Literature DB >> 12964914

Lowering blood pressure in 2003.

John P Chalmers1, Leonard F Arnolda.   

Abstract

The foundation of treatment for patients with hypertension is ongoing use of lifestyle measures such as physical exercise, weight reduction, and salt restriction. There should be emphasis on reduction of total cardiovascular risk, including smoking cessation and achievement of goal blood pressures. There are now five classes of first-line blood-pressure-lowering drugs - diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium antagonists. In most patients, the choice of drug will be guided by the clinical situation in the individual patient, including the presence of target organ damage, diabetes, established vascular or kidney disease, or other comorbidities. In the absence of such clinical indications, start drug therapy with a low-dose diuretic. Combination therapy will be needed in around two-thirds of patients, and a diuretic will normally form one element of most combinations, with the second or third drug coming from among the remaining four. Consider the use of fixed-dose combinations to improve adherence to therapy. Use long-acting, once-daily preparations.

Entities:  

Mesh:

Year:  2003        PMID: 12964914

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

Review 1.  Applied Healthspan engineering.

Authors:  James W Larrick; Andrew Mendelsohn
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

Review 2.  Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics.

Authors:  Paolo Palatini
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

3.  Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study.

Authors:  Brett D Montgomery; Peter R Mansfield; Geoffrey K Spurling; Alison M Ward
Journal:  BMC Public Health       Date:  2008-05-20       Impact factor: 3.295

Review 4.  Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk.

Authors:  H Haller
Journal:  Int J Clin Pract       Date:  2008-03-17       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.